These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9619805)

  • 1. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype.
    Di Stefano M; Monno L; Fiore JR; Buccoliero G; Appice A; Perulli LM; Pastore G; Angarano G
    AIDS; 1998 May; 12(7):737-43. PubMed ID: 9619805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human immunodeficiency virus biological phenotypes isolated from cerebrospinal fluid and peripheral blood.
    Peeters MF; Colebunders RL; Van den Abbeele K; Nys PC; Goeman J; Colans P; Geerts Y; Van der Groen G
    J Med Virol; 1995 Sep; 47(1):92-6. PubMed ID: 8551266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
    Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.
    Karlsson U; Antonsson L; Ljungberg B; Medstrand P; Esbjörnsson J; Jansson M; Gisslen M
    AIDS; 2012 Sep; 26(14):1739-44. PubMed ID: 22695299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
    García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
    AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count.
    Kupfer B; Kaiser R; Rockstroh JK; Matz B; Schneweis KE
    J Med Virol; 1998 Nov; 56(3):259-63. PubMed ID: 9783695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    Arq Neuropsiquiatr; 2005 Dec; 63(4):907-13. PubMed ID: 16400403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease.
    Verhofstede C; Reniers S; Van Wanzeele F; Plum J
    AIDS; 1994 Oct; 8(10):1421-7. PubMed ID: 7529507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients.
    Bagaglio S; Cinque P; Racca S; Pedale R; Grasso MA; Lazzarin A; Morsica G
    AIDS; 2005 Oct; 19 Suppl 3():S151-65. PubMed ID: 16251813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
    Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
    J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    Trunfio M; Rugge W; Mighetto L; Vai D; Atzori C; Nigra M; Domini S; Borgogno E; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
    AIDS; 2020 Nov; 34(13):1899-1906. PubMed ID: 32701580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of correlation between cerebrospinal fluid and plasma HIV-1 RNA levels in patients with neurological opportunistic diseases.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    Rev Inst Med Trop Sao Paulo; 2011; 53(4):193-6. PubMed ID: 21915461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
    Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
    BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood-brain barrier damage.
    Bavaro DF; Calamo A; Lepore L; Fabrizio C; Saracino A; Angarano G; Monno L
    Infection; 2019 Jun; 47(3):441-446. PubMed ID: 30649685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pegivirus-1 in the CSF of patients with HIV-associated neurocognitive disorder (HAND) may be derived from blood in highly viraemic patients.
    Hardie D; Smuts H
    J Clin Virol; 2017 Jun; 91():58-61. PubMed ID: 28499138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
    Cinque P; Bestetti A; Morelli P; Presi S
    J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
    Abebe A; Demissie D; Goudsmit J; Brouwer M; Kuiken CL; Pollakis G; Schuitemaker H; Fontanet AL; Rinke de Wit TF
    AIDS; 1999 Jul; 13(11):1305-11. PubMed ID: 10449282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
    Ulfhammer G; Edén A; Antinori A; Brew BJ; Calcagno A; Cinque P; De Zan V; Hagberg L; Lin A; Nilsson S; Oprea C; Pinnetti C; Spudich S; Trunfio M; Winston A; Price RW; Gisslén M
    Clin Infect Dis; 2022 Aug; 75(3):493-502. PubMed ID: 34747481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.